Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis
Bill & Melinda Gates Foundation as part of the WHO Pneumococcal Vaccines Technical Coordination Project.
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:20.500.12328/5103 |
| Acceso en línea: | http://hdl.handle.net/20.500.12328/5103 https://doi.org/10.1016/S1473-3099(24)00588-7 |
| Access Level: | acceso abierto |
| Palabra clave: | invasive pneumococcal disease enfermedad neumocócica invasiva malaltia pneumocòcica invasiva 61 |
| Sumario: | Bill & Melinda Gates Foundation as part of the WHO Pneumococcal Vaccines Technical Coordination Project. |
|---|